T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.07% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.39% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Brown-Forman Class A
BF.A
$13.1B
| $2.43M | ﹤0.01% |
36,000
| – | – |
|
1377
Gentex
GNTX
$5B
| $2.43M | ﹤0.01% |
101,777
-3,464
| -3% | -$95.1K |
|
1378
ITT
ITT
$19.6B
| $2.41M | ﹤0.01% |
36,854
+762
| +2% | +$55.6K |
|
1379
ESAB
ESAB
$5.32B
| $2.41M | ﹤0.01% |
72,162
-6,001,201
| -99% | -$246M |
|
1380
Harmonic Inc
HLIT
$1.49B
| $2.41M | ﹤0.01% |
184,027
-17,270,919
| -99% | -$187M |
|
1381
Qiagen
QGEN
$8.96B
| $2.4M | ﹤0.01% |
54,871
+26,980
| +97% | +$1.33M |
|
|
LHCG
1382
DELISTED
LHC Group LLC
LHCG
| $2.39M | ﹤0.01% |
14,609
-261
| -2% | -$42.3K |
|
1383
Donaldson
DCI
$11.1B
| $2.38M | ﹤0.01% |
48,581
+6,506
| +15% | +$340K |
|
1384
Alamo Group
ALG
$2.02B
| $2.38M | ﹤0.01% |
19,460
-844,603
| -98% | -$107M |
|
1385
CTS Corp
CTS
$1.81B
| $2.37M | ﹤0.01% |
56,961
-3,093,584
| -98% | -$124M |
|
1386
Westlake Corp
WLK
$10.2B
| $2.37M | ﹤0.01% |
27,309
+3,168
| +13% | +$304K |
|
1387
Sabra Healthcare REIT
SBRA
$5.1B
| $2.37M | ﹤0.01% |
180,627
+28,878
| +19% | +$427K |
|
1388
Chemours
CC
$2.38B
| $2.37M | ﹤0.01% |
96,126
+673
| +0.7% | +$22.2K |
|
1389
MasTec
MTZ
$23.3B
| $2.36M | ﹤0.01% |
37,173
-4,118
| -10% | -$319K |
|
1390
Parsons
PSN
$5.06B
| $2.36M | ﹤0.01% |
60,173
-3,871,633
| -98% | -$161M |
|
1391
Ameris Bancorp
ABCB
$6.03B
| $2.35M | ﹤0.01% |
52,605
+4,230
| +9% | +$194K |
|
1392
Cedar Fair
FUN
$1.71B
| $2.35M | ﹤0.01% |
57,138
-645,438
| -92% | -$27.5M |
|
|
WCC
1393
WESCO International
WCC
$17.6B
| $2.35M | ﹤0.01% |
19,645
+3,528
| +22% | +$441K |
|
|
CIVI
1394
DELISTED
Civitas Resources
CIVI
| $2.32M | ﹤0.01% |
40,381
+3,389
| +9% | +$200K |
|
|
CADE
1395
DELISTED
Cadence Bank
CADE
| $2.32M | ﹤0.01% |
91,152
-2,822,208
| -97% | -$72.5M |
|
1396
Woodside Energy
WDS
$44B
| $2.31M | ﹤0.01% |
114,420
-27,958
| -20% | -$616K |
|
1397
Encompass Health
EHC
$12.1B
| $2.3M | ﹤0.01% |
50,925
-1,364
| -3% | -$68.2K |
|
1398
Matsons
MATX
$6.47B
| $2.3M | ﹤0.01% |
37,364
-67,723
| -64% | -$5.2M |
|
1399
Interactive Brokers
IBKR
$41.3B
| $2.3M | ﹤0.01% |
143,732
+28,676
| +25% | +$442K |
|
1400
Lyft
LYFT
$6.53B
| $2.3M | ﹤0.01% |
174,312
+5,971
| +4% | +$91.9K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.